PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Covance Inc, Princeton, NJ, USA.\', \'East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK.\', \'Institut Jules Bordet, Brussels, Belgium.\', \'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.\', \'IOB Institute of Oncology, Quiron Group, Madrid, Spain.\', \'Vall d\'Hebron Institute of Oncology, Barcelona, Spain.\', \'Medica Scientia Innovation Research, Ridgewood, NJ, USA.\', \'Madrid Medical Doctors Association, Madrid, Spain.\', \'La Paz Hospital, Madrid, Spain.\', \'HistoGeneX, Antwerp, Belgium.\', \'GBG, Neu-Isenburg, Germany.\', \'Centre for Haematology and Oncology Bethanien, Frankfurt, Germany.\', \'Istituto Europeo di Oncologia, IRCCS, Milan, Italy.\', \'University of Milano, Milan, Italy.\', \'University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK.\', \'Covance Inc, Princeton, NJ, USA. Manuela.Leone@covance.com.\', \'Mayo Clinic, Rochester, MN, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41416-020-0948-x
?:doi
?:hasPublicationType
?:journal
  • British journal of cancer
is ?:pmid of
?:pmid
?:pmid
  • 32572174
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.89
?:rankingScore_hIndex
  • 204
is ?:relation_isRelatedTo_publication of
?:title
  • Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32572174>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32572174>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all